Seeking Alpha

China Biologic Products (CBPO -6.5%) takes a hit today after receiving notification from the...

China Biologic Products (CBPO -6.5%) takes a hit today after receiving notification from the Guizhou Provincial Health Department that the government has suspended the company's blood collection activities in the province. The suspension affects four of six collection sites it runs, and the impact upon current business operations could be significant.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|